首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix
【2h】

Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix

机译:分类疫苗犹豫不决原因的趋势在世界卫生组织/儿童基金会联合报告表中报告2014 - 2017年:疫苗犹豫不决矩阵的使用和可比性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since 2014, the World Health Organization (WHO) member states have been annually reporting vaccine hesitancy reasons, using the WHO/UNICEF Joint Reporting Form (JRF). The Vaccine Hesitancy Matrix (VHM), developed by a WHO strategic advisory group of experts, can serve as an important tool to categorize vaccine hesitancy reasons reported in the JRF. We aimed to describe the reasons for vaccine hesitancy reported globally from 2014 to 2017 to ascertain trends over time and understand the comparability of using the VHM to classify hesitancy reasons from 2014 to 2016 based on previously published literature. We conducted a quantitative content analysis to code and categorize vaccine hesitancy reasons reported in the JRF from 2014 to 2017. Vaccine hesitancy trends were consistent from 2014 to 2017, where vaccine hesitancy reasons were mainly related to “individual and group level influences” (59%) followed by “contextual influences” (25%), and “vaccine- or vaccination-specific issues” (16%). Comparability of our approach to categorize vaccine hesitancy to the previously published JRF data showed that results were mostly but not entirely consistent. Major differences in categorizing vaccine hesitancy were noted between two specific reasons – “experience with past vaccination” (under “individual and group influences”) and “risk/benefit- scientific evidence” (under “vaccine and vaccination-specific issues”); this was usually due to lack of clear definitions in some sub-categories and generic responses reported in the JRF. The JRF hesitancy module may benefit from modifications to improve the data quality. Understanding global vaccine hesitancy is crucial and JRF can serve as an important tool, especially with the potential introduction of a COVID-19 vaccine.
机译:自2014年,世界卫生组织(WHO)成员国已报告每年疫苗犹豫不决的原因,使用WHO / UNICEF联合报告表(JRF)。该疫苗犹豫不决矩阵(VHM),由专家组成的世卫组织战略咨询小组开发的,可以作为在JRF报道群归类疫苗犹豫不决的原因的重要工具。我们的目的是描述疫苗犹豫不决的原因2014至17年全球报告,以确定趋势,随着时间的推移和了解使用VHM分类犹豫的原因,从2014年基于先前发表的文献2016可比性。我们进行了定量的内容分析,在JRF报道从2014年2017年疫苗犹豫不决趋势码和分类疫苗犹豫不决原因是2014至2017年,在疫苗犹豫不决的原因主要涉及“个人和团体层面的影响”是一致的(59% ),接着“上下文相关的影响”(25%),和“特定疫苗接种疫苗可或者问题”(16%)。我们的方法来分类疫苗犹豫不决先前公布的JRF的数据进行比较显示,业绩大多但并不完全一致。在归类疫苗犹豫不决的主要区别有两个具体原因之间的指出 - “以往接种的经验”(“个人和团体的影响”下)和“风险/惠益的科学证据”(“疫苗和具体疫苗接种问题”下);这通常是由于缺乏在JRF报告的一些子类明确的定义和一般反应。的JRF踌躇模块可以从修改受益,以提高数据质量。了解全球疫苗犹豫不决是至关重要的,JRF可以作为一个重要的工具,尤其是与潜在的引进COVID-19疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号